By: Christopher Parrella, Esq., CPC, CHC, CPCO

Parrella Health Law, Boston, MA

A Health Care Provider Defense and Compliance Firm

The False Claims Act landscape is changing quickly. Health care providers have long focused on the risk posed by internal whistleblowers such as coders, billing staff, clinicians, compliance officers, and former executives. That risk remains. But providers now face a new category of relator who may have no connection to the organization at all. Artificial intelligence is allowing outside data miners to analyze public claims information, government databases, reimbursement trends, and corporate records in search of patterns that may support a qui tam lawsuit. These relators do not need access to internal emails or confidential documents. They identify statistical anomalies and then use AI to build detailed allegations around what the data appears to show.

The number of qui tam complaints reflects how quickly this trend is growing. Last year, 1,297 new whistleblower complaints were filed compared with 980 in 2024. According to the Department of Justice, data miners have been responsible for nearly half of all qui tam filings since 2024. The financial incentive is significant. False Claims Act settlements and judgments exceeded $6.8 billion in fiscal year 2025, and successful relators may receive a substantial share of the recovery.

The greatest danger for providers is that an AI-generated allegation can be wrong and still be extremely expensive. A provider may appear to be an outlier because it treats a more complex patient population, operates a specialized program, or serves a unique geographic area. An algorithm may not understand that context.

A data miner may see high utilization and conclude that services were unnecessary. It may see frequent use of a particular code and infer upcoding. It may compare reimbursement across providers without accounting for differences in acuity, licensure, setting, or payer guidance. Once those assumptions are placed into a lengthy complaint with citations and technical analysis, they may appear more persuasive than the underlying data deserves.

Even a flawed theory can trigger a subpoena. Providers may still be forced to retain counsel, preserve documents, collect data, interview employees, and respond to government demands before the allegation is disproven. DOJ recently launched the Fraud Oversight through Careful Use of Statistics initiative known as FOCUS. The program is designed to encourage sophisticated data miners to explain how they identify fraud, validate their findings, and connect data signals to legally sufficient allegations. While DOJ says it wants reliable analysis rather than speculative complaints, a private relator may continue pursuing a case even when the government declines to intervene.

Providers should assume their claims data is already being reviewed. Compliance programs must therefore become more data-driven. Organizations should examine coding trends, modifier use, utilization rates, clinician outliers, referral patterns, and rapid growth in particular service lines. An unusual pattern does not necessarily mean fraud, but the organization should understand the reason and document it.

The call to action is direct. Conduct an FCA-focused data review before an outside relator does it for you. Investigate statistical outliers, preserve legitimate clinical explanations, and correct actual billing problems promptly. Strengthen internal reporting channels so employees bring concerns to compliance before contacting outside counsel or the government.  Your next whistleblower may not work inside your organization. It may be an algorithm reviewing your public claims from hundreds of miles away.

If you have questions about False Claims Act exposure or want Parrella Health Law to conduct a proactive claims data risk assessment, please contact us at 857.328.0382 or contact Chris directly at cparrella@parrellahealthlaw.com.